IPCA LABORATORIES Financial Statement Analysis
|
||
The Revenues of IPCA LABORATORIES have increased by 7.45% YoY .
The Earnings Per Share (EPS) of IPCA LABORATORIES has decreased by -46.69 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
IPCA LABORATORIES Last 5 Annual Financial Results
[BOM: 524494|NSE : IPCALAB]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹5,797 Cr | ₹5,395 Cr | ₹4,619 Cr | ₹3,746 Cr | ₹3,258 Cr |
Expenses | ₹4,539 Cr | ₹3,914 Cr | ₹3,729 Cr | ₹3,067 Cr | ₹2,816 Cr |
Operating Profit (Excl OI) | ₹1,258 Cr | ₹1,481 Cr | ₹890 Cr | ₹678 Cr | ₹442 Cr |
Other Income | ₹122 Cr | ₹129 Cr | ₹87 Cr | ₹75 Cr | ₹58 Cr |
Interest | ₹11 Cr | ₹12 Cr | ₹20 Cr | ₹22 Cr | ₹28 Cr |
Depreciation | ₹232 Cr | ₹209 Cr | ₹211 Cr | ₹182 Cr | ₹178 Cr |
Profit Before Tax | ₹1,136 Cr | ₹1,389 Cr | ₹739 Cr | ₹546 Cr | ₹291 Cr |
Profit After Tax | ₹911 Cr | ₹1,149 Cr | ₹604 Cr | ₹442 Cr | ₹239 Cr |
Consolidated Net Profit | ₹884 Cr | ₹1,140 Cr | ₹606 Cr | ₹446 Cr | ₹239 Cr |
Earnings Per Share (Rs) | ₹18.58 | ₹34.85 | ₹89.87 | ₹47.99 | ₹35.27 |
PAT Margin (%) | 7.88 | 15.63 | 21.20 | 12.98 | 11.72 |
ROE(%) | 8.70 | 17.92 | 27.63 | 17.92 | 15.22 |
ROCE(%) | 11.71 | 20.46 | 30.92 | 19.71 | 16.48 |
Total Debt/Equity(x) | 0.25 | 0.14 | 0.05 | 0.13 | 0.15 |
Key Financials |
||
Market Cap | : | ₹ 33,960.3 Cr |
Revenue (TTM) | : | ₹ 7,186.0 Cr |
Net Profit(TTM) | : | ₹ 607.4 Cr |
EPS (TTM) | : | ₹ 23.9 |
P/E (TTM) | : | 55.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
IPCA LABORATORIES | 0.7% | 11.8% | 60.8% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
IPCA LABORATORIES Revenues
[BOM: 524494|NSE : IPCALAB]
Y-o-Y | 7.45 % |
5 Yr CAGR | 15.50 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹5,797 Cr | 7.45 | |
Mar2022 | ₹5,395 Cr | 16.80 | |
Mar2021 | ₹4,619 Cr | 23.32 | |
Mar2020 | ₹3,746 Cr | 14.98 | |
Mar2019 | ₹3,258 Cr | - |
IPCA LABORATORIES Operating Profit
[BOM: 524494|NSE : IPCALAB]
Y-o-Y | -15.10 % |
5 Yr CAGR | 29.88 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1,258 Cr | -15.10 | |
Mar2022 | ₹1,481 Cr | 66.34 | |
Mar2021 | ₹890 Cr | 31.29 | |
Mar2020 | ₹678 Cr | 53.46 | |
Mar2019 | ₹442 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -20.98 % |
5 Yr CAGR | 12.45 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 21.7% | -20.98 | |
Mar2022 | 27.46% | 42.43 | |
Mar2021 | 19.28% | 6.46 | |
Mar2020 | 18.11% | 33.46 | |
Mar2019 | 13.57% | - |
IPCA LABORATORIES Profit After Tax
[BOM: 524494|NSE : IPCALAB]
Y-o-Y | -22.45 % |
5 Yr CAGR | 38.62 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹884 Cr | -22.45 | |
Mar2022 | ₹1,140 Cr | 88.02 | |
Mar2021 | ₹606 Cr | 36.07 | |
Mar2020 | ₹446 Cr | 86.11 | |
Mar2019 | ₹239 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -49.58 % |
5 Yr CAGR | -9.45 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 7.88 % | -49.58 | |
Mar2022 | 15.63 % | -26.27 | |
Mar2021 | 21.2 % | 63.33 | |
Mar2020 | 12.98 % | 10.75 | |
Mar2019 | 11.72 % | - |
IPCA LABORATORIES Earnings Per Share (EPS)
[BOM: 524494|NSE : IPCALAB]
Y-o-Y | -46.69 % |
5 Yr CAGR | -14.81 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹19 | -46.69 | |
Mar2022 | ₹35 | -61.22 | |
Mar2021 | ₹90 | 87.27 | |
Mar2020 | ₹48 | 36.06 | |
Mar2019 | ₹35 | - |
IPCA LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524494|NSE : IPCALAB]
Y-o-Y | -42.77 % |
5 Yr CAGR | -8.19 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 11.71% | -42.77 | |
Mar2022 | 20.46% | -33.83 | |
Mar2021 | 30.92% | 56.87 | |
Mar2020 | 19.71% | 19.60 | |
Mar2019 | 16.48% | - |
IPCA LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹1,338.6 |
Current MarketCap | : | ₹ 33,960.3 Cr |
Updated EOD on | : | Apr 26,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | 0.7% |
11.8% |
60.8% |
SENSEX | 0.9% |
1.5% |
23.6% |
IPCA LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 4% | 9.7% | 67.3% |
S&P BSE MID CAP | 4% | 7.6% | 67.4% |
S&P BSE 400 MIDSMALLCAP | 3.8% | 9.1% | 62% |
S&P BSE 150 MIDCAP | 3.6% | 7.7% | 59.6% |
S&P BSE HEALTHCARE | 3% | 4% | 55.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY200 MOMENTUM 30 INDEX | 4.8% | 7.4% | 72.2% |
NIFTY FREE MIDCAP 100 | 4% | 7.6% | 62.8% |
NIFTY MID SMALL400 | 3.9% | 9.6% | 64.8% |
NIFTY MIDCAP150 | 3.7% | 8% | 60.4% |
NIFTY HEALTHCARE | 3.2% | 2.5% | 51.3% |
You may also like the below Video Courses
FAQ about IPCA LABORATORIES Financials
How the annual revenues of IPCA LABORATORIES have changed ?
The Revenues of IPCA LABORATORIES have increased by 7.45% YoY .
How the Earnings per Share (EPS) of IPCA LABORATORIES have changed?
The Earnings Per Share (EPS) of IPCA LABORATORIES has decreased by -46.69 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs